Burgers SA[au] - Search Results

Year	Number of Results
1996	1
1999	1
2000	1
2002	1
2003	2
2004	5
2005	2
2008	1
2009	5
2010	2
2011	1
2012	4
2013	1
2014	5
2015	5
2016	1
2022	2
2023	3
2024	1

1

Crizotinib-induced fatal fulminant liver failure.

van Geel RM, Hendrikx JJ, Vahl JE, van Leerdam ME, van den Broek D, Huitema AD, Beijnen JH, Schellens JH, Burgers SA. van Geel RM, et al. Among authors: burgers sa. Lung Cancer. 2016 Mar;93:17-9. doi: 10.1016/j.lungcan.2015.12.010. Epub 2015 Dec 30. Lung Cancer. 2016. PMID: 26898609

2

Prevalence and Predictors of Physician-Patient Discordance in Prognostic Perceptions in Advanced Cancer.

van der Velden NCA, Han PKJ, van Laarhoven HWM, de Vos FYFL, Hendriks LEL, Burgers SA, Dingemans AC, van Haarst JMW, Dits J, Smets EMA, Henselmans I. van der Velden NCA, et al. Among authors: burgers sa. Oncologist. 2023 Aug 3;28(8):e653-e668. doi: 10.1093/oncolo/oyad098. Oncologist. 2023. PMID: 37159001 Free PMC article.

3

Immunotherapy in non-small-cell lung carcinoma: from inflammation to vaccination.

Van den Heuvel MM, Burgers SA, van Zandwijk N. Van den Heuvel MM, et al. Among authors: burgers sa. Clin Lung Cancer. 2009 Mar;10(2):99-105. doi: 10.3816/CLC.2009.n.012. Clin Lung Cancer. 2009. PMID: 19362952 Review.

4

Characteristics of patients with advanced cancer preferring not to know prognosis: a multicenter survey study.

van der Velden NCA, van Laarhoven HWM, Burgers SA, Hendriks LEL, de Vos FYFL, Dingemans AC, Jansen J, van Haarst JW, Dits J, Smets EM, Henselmans I. van der Velden NCA, et al. Among authors: burgers sa. BMC Cancer. 2022 Sep 1;22(1):941. doi: 10.1186/s12885-022-09911-8. BMC Cancer. 2022. PMID: 36050628 Free PMC article.

5

Modeling strategies to analyse longitudinal biomarker data: An illustration on predicting immunotherapy non-response in non-small cell lung cancer.

van Delft FA, Schuurbiers M, Muller M, Burgers SA, van Rossum HH, IJzerman MJ, Koffijberg H, van den Heuvel MM. van Delft FA, et al. Among authors: burgers sa. Heliyon. 2022 Oct 4;8(10):e10932. doi: 10.1016/j.heliyon.2022.e10932. eCollection 2022 Oct. Heliyon. 2022. PMID: 36254284 Free PMC article.

6

Prognostic Value of Nivolumab Clearance in Non-Small Cell Lung Cancer Patients for Survival Early in Treatment.

Otten LS, Piet B, van den Haak D, Schouten RD, Schuurbiers M, Badrising SK, Boerrigter E, Burgers SA, Ter Heine R, van den Heuvel MM. Otten LS, et al. Among authors: burgers sa. Clin Pharmacokinet. 2023 Dec;62(12):1749-1754. doi: 10.1007/s40262-023-01316-5. Epub 2023 Oct 19. Clin Pharmacokinet. 2023. PMID: 37856040 Free PMC article.

7

Identification of protein biomarkers for prediction of response to platinum-based treatment regimens in patients with non-small cell lung cancer.

Böttger F, Radonic T, Bahce I, Monkhorst K, Piersma SR, Pham TV, Dingemans AC, Hillen LM, Santarpia M, Giovannetti E, Smit EF, Burgers SA, Jimenez CR. Böttger F, et al. Among authors: burgers sa. Mol Oncol. 2023 Nov 27. doi: 10.1002/1878-0261.13555. Online ahead of print. Mol Oncol. 2023. PMID: 38010703 Free article.

8

Comparing modeling strategies combining changes in multiple serum tumor biomarkers for early prediction of immunotherapy non-response in non-small cell lung cancer.

van Delft FA, Schuurbiers MMF, Muller M, Burgers SA, van Rossum HH, IJzerman MJ, van den Heuvel MM, Koffijberg H. van Delft FA, et al. Among authors: burgers sa. Tumour Biol. 2024;46(s1):S269-S281. doi: 10.3233/TUB-220022. Tumour Biol. 2024. PMID: 37545289 Free article.

9

DNA hypermethylation analysis in sputum for the diagnosis of lung cancer: training validation set approach.

Hubers AJ, Heideman DA, Burgers SA, Herder GJ, Sterk PJ, Rhodius RJ, Smit HJ, Krouwels F, Welling A, Witte BI, Duin S, Koning R, Comans EF, Steenbergen RD, Postmus PE, Meijer GA, Snijders PJ, Smit EF, Thunnissen E. Hubers AJ, et al. Among authors: burgers sa. Br J Cancer. 2015 Mar 17;112(6):1105-13. doi: 10.1038/bjc.2014.636. Br J Cancer. 2015. PMID: 25719833 Free PMC article.

10

Timing of metabolic response monitoring during erlotinib treatment in non-small cell lung cancer.

van Gool MH, Aukema TS, Schaake EE, Rijna H, Valdés Olmos RA, van Pel R, Burgers SA, van Tinteren H, Klomp HM; NEL Study Group. van Gool MH, et al. Among authors: burgers sa. J Nucl Med. 2014 Jul;55(7):1081-6. doi: 10.2967/jnumed.113.130674. Epub 2014 May 8. J Nucl Med. 2014. PMID: 24812245 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

37 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year